IDEAYA Biosciences
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2015-01-01
- Employees
- 124
- Market Cap
- $3.3B
- Website
- http://www.ideayabio.com
- Introduction
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
IDEAYA Biosciences Appoints Stu Dorman as CCO
The article discusses the importance of enabling JavaScript for optimal app performance.
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
IDEAYA Biosciences appoints Stu Dorman as Chief Commercial Officer, leveraging his 20+ years of oncology commercialization experience from Gilead Sciences and Bristol Myers Squibb, including successful launches of Trodelvy® and Opdivo®.
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis
IDEAYA Biosciences, Inc. (IDYA) is a precision medicine oncology firm with a $1.2 billion cash reserve and a strong pipeline, including darovasertib in Phase 2/3 trials. Despite significant collaborations and financial backing, it faces a $492.5 million deficit and relies on external financing. Its future hinges on clinical trial success and regulatory approvals.
PESTEL Analysis of IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA) navigates a complex biotech landscape influenced by political, economic, social, technological, legal, and environmental factors. Key points include regulatory impacts on drug approval, collaboration with GSK, R&D expenses, public interest in personalized medicine, advancements in precision medicine, intellectual property rights, and sustainable practices. Strategic adaptability is crucial for market positioning and innovation in cancer treatment.
© Copyright 2025. All Rights Reserved by MedPath